American College of Radiology Association Announces Scope of Practice Fund Recipients

Four state radiological societies have been awarded grants from the American College of Radiology Association® (ACRA®) Scope of Practice (SOP) Fund. Societies receiving initial funds are Kansas, New York, Pennsylvania and Wisconsin.

The SOP fund was established in 2021 by the ACRA to safeguard patients and patient access to radiologist expertise by fighting state and federal non-physician SOP expansion legislation. Non-physician provider groups continually seek expanded authority by introducing legislation that would, for example, reduce radiologist oversight and enable direct billing.

“Our state radiological societies continue to be on the front lines of dangerous scope of practice expansion efforts that would threaten patient safety and erode access to high quality radiological care,” said Howard B. Fleishon, MD, MMM, FACR, Chair of the American College of Radiology® (ACR®) Board of Chancellors. “The ACRA is committed to helping these state radiological societies as they work to educate lawmakers about the importance of radiologists and radiologist-led teams, and the SOP fund is one tool that can assist with their efforts.”

For more information about the fund and ACR scope of practice activities, visit the ACR SOP microsite.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.